Published in Obesity and Diabetes Week, February 13th, 2006
According to a recent review from Japan, "The beta3 -adrenergic receptor (beta3 -AR) has been shown to mediate various pharmacological and physiological effects such as lipolysis, thermogenesis, and relaxation of the urinary bladder. Activation of the beta(3)-AR is thought to be a possible approach for the treatment of obesity, type 2 diabetes mellitus, and frequent urination."
"Therefore, the beta3 -AR is recognized as an attractive target for drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week